ZBD Pharma Gets China Approval for Antibacterial Injection

MT NewswiresDec 3 02:59 ET

Heilongjiang ZBD Pharmaceutical Co., Ltd.'s (SHSE:603567) Stock Price Dropped 3.8% Last Week; Private Equity Firms Would Not Be Happy

Simply Wall StNov 18 22:22 ET

Report for the third quarter of 2024 of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.

SZSIOct 29 12:00 ET · Announcements

While Shareholders of Heilongjiang ZBD Pharmaceutical (SHSE:603567) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown

Simply Wall StOct 25 00:39 ET

We Think Heilongjiang ZBD Pharmaceutical (SHSE:603567) Can Stay On Top Of Its Debt

Simply Wall StOct 3 23:52 ET

China Rejects ZBD Pharmaceutical's Application For Skin Infection Drug

MT NewswiresAug 27 01:56 ET